ADX40-TB

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameADX40-TB

Drug Alias Nametuberculosis vaccine (ADX-40 adjuvant) (Adjuvantix)ADX40-TB

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugate

Mechanisms of ActionCD40 ligand modulators

TargetsCD40 ligand

Therapy Area/IndicationsTuberculosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAdjuvantix Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAdjuvantix Ltd

Active IndicationsN/A

Inactive IndicationsTuberculosis

Other Information

ATC CodeN/A